Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in malawian adults on stavudine containing highly active antiretroviral therapy.

Kampira E, Kumwenda J, van Oosterhout JJ, Dandara C.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):647-52. doi: 10.1097/QAI.0b013e3182968ea5.

2.

Mitochondrial subhaplogroups and differential risk of stavudine-induced lipodystrophy in Malawian HIV/AIDS patients.

Kampira E, Kumwenda J, Van Oosterhout JJ, Dandara C.

Pharmacogenomics. 2013 Dec;14(16):1999-2004. doi: 10.2217/pgs.13.188.

PMID:
24279854
3.

Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.

Kampira E, Dzobo K, Kumwenda J, van Oosterhout JJ, Parker MI, Dandara C.

OMICS. 2014 Jul;18(7):438-45. doi: 10.1089/omi.2014.0026. Epub 2014 May 9.

PMID:
24816082
4.

African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.

Canter JA, Robbins GK, Selph D, Clifford DB, Kallianpur AR, Shafer R, Levy S, Murdock DG, Ritchie MD, Haas DW, Hulgan T; AIDS Clinical Trials Group Study 384 Team; New Work Concept Sheet 273 Team.

J Infect Dis. 2010 Jun 1;201(11):1703-7. doi: 10.1086/652419.

5.

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.

Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Kallianpur AR, Summar M, Canter JA.

AIDS. 2005 Sep 2;19(13):1341-9.

PMID:
16103764
6.

Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.

Kallianpur AR, Hulgan T, Canter JA, Ritchie MD, Haines JL, Robbins GK, Shafer RW, Clifford DB, Haas DW.

AIDS. 2006 Jul 13;20(11):1503-13.

PMID:
16847405
7.

Severe toxicity and polymerase-γ gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy.

van Oosterhout JJ, Gardner K, Mallewa J, Kaunda S, Kampira E, Payne B, Heyderman RS, Chinnery P.

Pharmacogenet Genomics. 2013 Nov;23(11):624-6. doi: 10.1097/FPC.0b013e3283655053.

PMID:
23962909
8.

Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.

Kiwuwa-Muyingo S, Kikaire B, Mambule I, Musana H, Musoro G, Gilks CF, Levin JB, Walker AS.

AIDS. 2014 Nov 13;28(17):2579-88. doi: 10.1097/QAD.0000000000000447.

PMID:
25574960
9.

The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.

Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Murdock DG, Hulgan T.

Pharmacogenomics J. 2008 Feb;8(1):71-7. Epub 2007 Aug 7.

PMID:
17684475
10.

Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.

McGrath CJ, Njoroge J, John-Stewart GC, Kohler PK, Benki-Nugent SF, Thiga JW, Etyang A, Chung MH.

J Neurovirol. 2012 Jun;18(3):200-4. doi: 10.1007/s13365-012-0098-x. Epub 2012 Apr 17.

11.

Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities.

Chagoma N, Mallewa J, Kaunda S, Njalale Y, Kampira E, Mukaka M, Heyderman RS, van Oosterhout JJ.

Trans R Soc Trop Med Hyg. 2013 Oct;107(10):615-9. doi: 10.1093/trstmh/trt074. Epub 2013 Aug 7.

12.

Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.

Rosso R, Nasi M, Di Biagio A, Repetto E, Dentone C, Pinti M, Nemes E, Ferraresi R, Mussini C, Esposito R, Viscoli C, Cossarizza A.

Pediatr Infect Dis J. 2008 Jan;27(1):17-21.

PMID:
18162932
13.

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

van Oosterhout JJ, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, de Baar MP, Schuurman R, Burger DM, Zijlstra EE.

Trop Med Int Health. 2005 May;10(5):464-70.

14.

Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.

Shen Y, Wang J, Qi T, Wang Z, Lu H.

Int J STD AIDS. 2014 Jun;25(7):504-10. doi: 10.1177/0956462413515198. Epub 2013 Dec 10.

PMID:
24327726
15.

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study.

Sinxadi PZ, Dave JA, Samuels DC, Heckmann JM, Maartens G, Levitt NS, Wester CW, Haas DW, Hulgan T.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1031-9. doi: 10.1089/AID.2012.0373. Epub 2013 Mar 15.

16.

Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi.

Beadles WI, Jahn A, Weigel R, Clutterbuck D.

Trop Doct. 2009 Apr;39(2):78-80. doi: 10.1258/td.2008.080213.

PMID:
19299286
17.

Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.

Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, Dunkle LM.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):39-48.

PMID:
10534145
18.

Stavudine toxicity in adult longer-term ART patients in Blantyre, Malawi.

van Oosterhout JJ, Mallewa J, Kaunda S, Chagoma N, Njalale Y, Kampira E, Mukaka M, Heyderman RS.

PLoS One. 2012;7(7):e42029. doi: 10.1371/journal.pone.0042029. Epub 2012 Jul 26.

19.

Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.

Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, Mallal SA.

Antivir Ther. 2003 Aug;8(4):323-31.

PMID:
14518702
20.

T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.

Hulgan T, Robbins GK, Kalams SA, Samuels DC, Grady B, Shafer R, Murdock DG, Selph D, Haas DW, Pollard RB; AIDS Clinical Trials Group.

PLoS One. 2012;7(8):e43803. doi: 10.1371/journal.pone.0043803. Epub 2012 Aug 27.

Supplemental Content

Support Center